Levin Capital Strategies, L.P. Gilead Sciences, Inc. Transaction History

Levin Capital Strategies, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$57.92 - $72.58 $162,176 - $203,224	-2,800 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$64.88 - $73.64 $181,664 - $206,192	2,800 New	2,800 $203,000
Q1 2021 May 05, 2021	SELL	$60.0 - $68.46 $168,000 - $191,687	-2,800 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $158,620 - $180,740	2,800 New	2,800 $163,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Levin Capital Strategies, L.P., based on Form 13F filings with the SEC.

Stay updated on Levin Capital Strategies, L.P. with notifications on news.